SP747SUCCESSFUL HCV THERAPY WITH NOVEL DAA REGIMEN IMPROVES GLUCOSE TOLERANCE AND MAY PREVENT POST-TRANSPLANT DIABETES MELLITUS IN RENAL TRANSPLANT RECIPIENTS. (18th May 2018) - Bergfeld, Leon; Schrezenmeier, Eva; Lehner, Lukas; Staeck, Oliver; Khadzhynov, Dmytro; Eckardt, Kai-Uwe; Budde, Klemens; Halleck, Fabian; Duerr, Michael